跳至主要内容
临床试验/IRCT20120111008698N24
IRCT20120111008698N24招募中未知

Evaluating the role of intravenous Pentoxifylline administration on increasing primary percutaneous coronary intervention (PPCI) success in ST elevation myocardial infarction (STEMI) patient

Tehran University of Medical Sciences0 个研究点目标入组 320 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients older than 18 who are candidate for primary PCI.
  • Pain or chest discomfort greater than or equal to 20 minutes, less than or equal to 12 hours, and ST elevation = 1 mm in the adjacent limb leads and precordial leads except for V2, V3, or ST elevation = 2 mm in V2, V3 in men or ST height = 1.5 mm in V2, V3 in women.
  • Obtain informed consent from all patients before enrollment.

排除标准

  • Start angina more than 12 hours
  • CPR before transition to cath-lab
  • Patients with history of cardiac transplantation
  • Patients with history of PCI or CABG in last month
  • Patients who received thrombolytic
  • Current use of pentoxyfilline
  • Use of ketorolac in last 24 hours

研究者

相似试验